UK markets closed

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.17-0.28 (-3.31%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
1,239
4,046
9,862
4,159
Operating expenses
Research development
34,017
19,863
14,540
17,275
Selling general and administrative
20,410
15,202
6,187
6,681
Total operating expenses
54,427
35,065
20,727
23,956
Operating income or loss
-53,188
-31,019
-10,865
-19,797
Interest expense
1,737
1,874
2,388
2,680
Total other income/expenses net
940
836
-5,051
4,521
Income before tax
-53,942
-31,982
-18,155
-17,898
Income tax expense
127
238
490
109
Income from continuing operations
-54,069
-32,220
-18,645
-18,007
Net income
-54,069
-32,220
-18,645
-18,007
Net income available to common shareholders
-54,069
-32,220
-18,645
-18,346
Basic EPS
-
-0.36
-0.86
-2.90
Diluted EPS
-
-0.36
-0.86
-2.90
Basic average shares
-
88,296
21,570
6,316
Diluted average shares
-
88,296
21,570
6,316
EBITDA
-
-27,398
-12,171
-12,015